Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ana Emília, Brito"'
Autor:
Stefano Fanti, Matteo Bardisserotto, George B Coura-Filho, Diego B Piant, Fabio Peroba Esteves, Bruna Macedo, Bruno Hochhegger, Ana Maria Marques da Silva, Gustavo do Vale Gomes, Cinthia Scatolin Tem-Pass, Ana Emília Brito, Eduardo Mundstock, Wanderley Marques Bernardo, Cristina Sebastião Matushita, Diego H. Roman, Phelipi Nunes Schuck, Juliano Julio Cerci, Jonatas L Pereira, Bárbara Juarez Amorim
Publikováno v:
International Brazilian Journal of Urology, Vol 47, Iss 4, Pp 705-729 (2021)
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol, Volume: 47, Issue: 4, Pages: 705-729, Published: 30 JUL 2021
International braz j urol v.47 n.4 2021
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol, Volume: 47, Issue: 4, Pages: 705-729, Published: 30 JUL 2021
International braz j urol v.47 n.4 2021
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
Introduction: Prostate cancer (PC) is the second most commonly diagnosed cancer in males. 68Ga-PSMA PET/CT, a non-invasive diagnostic tool to evaluate PC with prostate-specific membrane antigen (PSMA) expression, has emerged as a more accurate altern
Autor:
Elba Etchebehere, Aline Lopes Garcia Leal, Ana Emília Brito, Felipe Alves Mourato, Paulo Almeida Filho, Maria Amorim Almeida
Publikováno v:
Clinical and Translational Imaging. 8:365-375
In patients with TENIS syndrome (Thyroglobulin-Elevated Negative Iodine Scintigraphy), PET/CT radiotracers, such FDG PET/CT and somatostatin analogs (SSTR PET/CT), can identify disease localization. Therefore, the objective of this paper is to compar
Autor:
Ana Emília Brito, Elba Etchebehere
Publikováno v:
Reference Module in Biomedical Sciences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57109a925d80a2ab9371ca7359740323
https://doi.org/10.1016/b978-0-12-822960-6.00020-x
https://doi.org/10.1016/b978-0-12-822960-6.00020-x
Autor:
Bárbara Juarez Amorim, Fabio Peroba Esteves, Ana Emília Brito, Wanderley Marques Bernardo, Gustavo do Vale Gomes, Cristina Sebastião Matushita
Publikováno v:
Revista da Associação Médica Brasileira, Vol 65, Iss 4, Pp 568-575 (2019)
Revista da Associação Médica Brasileira, Volume: 65, Issue: 4, Pages: 568-575, Published: 02 MAY 2019
Revista da Associação Médica Brasileira v.65 n.4 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 65, Issue: 4, Pages: 568-575, Published: 02 MAY 2019
Revista da Associação Médica Brasileira v.65 n.4 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through
Autor:
Fabio Peroba Esteves, Milena Martello, Gustavo do Vale Gomes, Ana Emília Brito, Bárbara Juarez Amorim, Cristina Sebastião Matushita, Wanderley Marques Bernardo
Publikováno v:
Revista da Associação Médica Brasileira, Vol 65, Iss 4, Pp 509-517 (2019)
Revista da Associação Médica Brasileira, Volume: 65, Issue: 4, Pages: 509-517, Published: 02 MAY 2019
Revista da Associação Médica Brasileira v.65 n.4 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 65, Issue: 4, Pages: 509-517, Published: 02 MAY 2019
Revista da Associação Médica Brasileira v.65 n.4 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize procedures to assist the reasoning and decision-making of doctors. The information provided through
Autor:
Homer Macapinlac, Elba Etchebehere, Eric M. Rohren, Ana Emília Brito, John Araujo, Kalevi Kairemo
Publikováno v:
Radiologia Brasileira, Vol 52, Iss 1, Pp 33-40
Radiologia Brasileira v.52 n.1 2019
Radiologia Brasileira
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR
Radiologia Brasileira v.52 n.1 2019
Radiologia Brasileira
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR
Objective: To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to
Autor:
Elba Etchebehere, Ana Emília Brito
Publikováno v:
Seminars in nuclear medicine. 50(2)
Radium-223 dichloride (223Ra) is an α-emitter radionuclide approved for treatment of osteoblastic metastases in castrate-resistant prostate cancer (mCRPC) patients. 223Ra increases overall survival, improves bone pain, increases the median time to t
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 44:84-96
Defining an optimal imaging modality for assessment of therapy and the best time of evaluation are pivotal for ideal patient’s management. 223Ra (Xofigo®, formerly Alpharadin) has been approved by the FDA and European Medicines Agency for treatmen
Autor:
Ana Emília Brito, Elba Etchebehere
Publikováno v:
Sodium Fluoride PET/CT in Clinical Use ISBN: 9783030235765
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::910df90d5916596845faa9fd3ef3c874
https://doi.org/10.1007/978-3-030-23577-2_5
https://doi.org/10.1007/978-3-030-23577-2_5
Autor:
Elba, Etchebehere, Ana Emília, Brito, Kalevi, Kairemo, Eric, Rohren, John, Araujo, Homer, Macapinlac
Publikováno v:
Radiologia Brasileira
Objective To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to t